‘The wild west:’ How an Alberta recreational retailer is addressing health-related cannabis inquiries
An Alberta recreational cannabis retailer is facing increasing health-related cannabis inquiries from consumers. This highlights the critical knowledge gap where retail staff provide medical guidance without training. Addressing this gap is essential for…
New Medical Cannabis Dispensary Improves Kentucky Patient Access
Kentucky medical cannabis access has expanded with the opening of a new dispensary in Paducah. This development improves patient access to regulated cannabis medicine in western Kentucky. Patients now benefit from safer, tested cannabis products without…
Our Opinion: Pennsylvania Must Embrace Recreational Cannabis Legalization
Pennsylvania recreational cannabis legalization could significantly broaden patient access beyond current medical restrictions. This shift would impact clinical counseling and regulatory frameworks. Understanding these changes is essential for healthcare…
. @crescolabs CEO: Rescheduling Ushers in a New Era of Medical Cannabis Patient Care –
Medical cannabis rescheduling regulatory impact is poised to transform research and patient care. This shift could enable more rigorous clinical trials and standardized treatment protocols. Patients and clinicians should stay informed about evolving…
Some Medical Marijuana to Be Reclassified: Nationwide Legal Impact?
The federal medical marijuana reclassification clinical implications could change how cannabis-based medicines are prescribed and researched. This shift may improve access to FDA-approved cannabis medications. However, it does not legalize recreational…
Trump DOJ Deregulates Marijuana to the Dismay of Health Experts – The Washington Stand
The Trump DOJ deregulates marijuana, affecting federal marijuana policy and clinical access to cannabis medicines. These changes influence patient care and research opportunities. Health experts express concern over the implications of this policy shift.
Trump Administration Updates Medical Marijuana Schedule III Reclassification
The medical marijuana schedule III reclassification update marks a significant federal policy shift. This change reduces research barriers and improves clinical access. It paves the way for expanded clinical trials and standardized prescribing.
Terrapin Urges State Action After DOJ Medical Marijuana Rescheduling
The DOJ medical marijuana rescheduling impact signals a major federal policy shift from Schedule I to Schedule III. This change could improve research access and reduce barriers for patients. States are now urged to adapt their medical cannabis programs…
State of Texas: Marijuana Reclassification and Medical Research Expansion
Texas marijuana reclassification could significantly expand medical research by removing regulatory barriers. This change may accelerate evidence-based clinical studies on cannabis therapeutics. Clinicians should monitor evolving research opportunities…
Governor Calls Medical Marijuana Rescheduling an ‘Important Step’
Medical marijuana federal rescheduling impacts are significant for clinical research and prescribing authority. This policy change could reduce regulatory barriers and expand medical access. Clinicians should stay informed about these evolving federal…